The University of Michigan will launch a new center to significantly accelerate drug development and assessment of the various outcomes associated with these treatments, while also reducing national health care expenditures.

The Center for Data-Driven Drug Development and Treatment Assessment — to be known as DATA — will support the use of machine learning and artificial intelligence techniques to research drug design, treatment assessment, repositioning, patient phenotyping and quantitative pharmacovigilance.